Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: FDA's Dental Products Panel Plaque Subcommittee

This article was originally published in The Tan Sheet

Executive Summary

FDA's Dental Products Panel Plaque Subcommittee: Will meet Oct. 29-30 from 8:30 a.m. to 5 p.m. at the Holiday Inn, Gaithersburg, Md. On Oct. 29, the committee will continue its discussion of, and may vote on, the safety and effectiveness of C31-G xylitol and zinc citrate, as well as combinations including: menthol/thymol/eucalyptol/menthol salicylate; hydrogen peroxide/povidone-iodine; hydrogen peroxide/sodium citrate; and zinc chloride/sodium lauryl sulfate. The committee also will continue its discussion of the criteria for OTC antiplaque and antigingivitis combination drug products. On Oct. 30, the committee will address final formulation testing for antiplaque/antigingivitis products, and will receive assignments for the review of foreign marketing data supporting antiplaque and antigingivitis ingredients. The subcommittee last discussed these issues in May ("The Tan Sheet" May 12, pp. 4-7)...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087524

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel